Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Talipexole to Pramipexole in Parkinson's Disease
NCT02231905Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Primary endpoint: Number of patients who prematurely discontinued due to adverse event at 12 weeks. Started Jan 2004; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02231905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231905.